Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cynamon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug AdministrationP Hopewell, M Cynamon, J Starke, et al.
The Journal of Biological Chemistry|February 25, 1981
Functional inactivation of lac alpha-peptide mRNA by a factor that purifies that Escherichia coli RNase IIIV Shen, M Cynamon, B Daugherty, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosisA Scorpio, P Lindholm-Levy, L Heifets, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2017
Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis TreatmentR M Anthony, M Cynamon, S Hoffner, et al.
Reviews of Infectious Diseases|July 1, 1985
Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infectionsD Trumbore, R Pontzer, M E Levison, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 3, 2009
Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in GeorgiaL Vashakidze, A Salakaia, N Shubladze, et al.
The New England Journal of Medicine|August 8, 1996
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndromeM Pierce, S Crampton, D Henry, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug AdministrationP Hopewell, M Cynamon, J Starke, et al.
The Journal of Biological Chemistry|February 25, 1981
Functional inactivation of lac alpha-peptide mRNA by a factor that purifies that Escherichia coli RNase IIIV Shen, M Cynamon, B Daugherty, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosisA Scorpio, P Lindholm-Levy, L Heifets, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2017
Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis TreatmentR M Anthony, M Cynamon, S Hoffner, et al.
Reviews of Infectious Diseases|July 1, 1985
Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infectionsD Trumbore, R Pontzer, M E Levison, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 3, 2009
Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in GeorgiaL Vashakidze, A Salakaia, N Shubladze, et al.
The New England Journal of Medicine|August 8, 1996
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndromeM Pierce, S Crampton, D Henry, et al.
Pageof 2